Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

The company will not be sold by October 16 unless it is already in process. If it is then so be it. But trying to force it to happen by eliminating the ability to forge a good non-dilutive deal will not work, because there will not be enough time before warrant expiration to do that. So trying to force a sale in order to save the warrants will simply screw the long term shareholders for a warrant pipe dream, by harming the company’s ability to negotiate an effective licensing deal to get us through the EMA process. Collaterally, if a good funding deal is struck the stock should recover to the point where the warrants are profitable, because when the cash issue is resolved there is nothing for shorts to look forward to other than possible EMA approval. This is the truth. Do not fall for the trap that is being set by the “vote against” idea. Let Lombardo have the tools that he says he needs to do the right thing, then judge the result.